Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.
暂无分享,去创建一个
C. Delaugerre | J. Molina | S. Gallien | R. Verdon | P. de Truchis | J. Braun | J. Reynes | J. Aboulker | T. May | I. Charreau | I. Madelaine-Chambrin | F. Jeanblanc